Magnetic resonance imaging of the central nervous system in diabetic neuropathy

Current Diabetes Reports

Volumn 13, Issue 4, 2013, Pages 509-516

  Wilkinson, Iain D ^a   Selvarajah, Dinesh ^a   Greig, Marni ^a,b   Shillo, Pallai ^a,b   Boland, Elaine ^a   Gandhi, Rajiv ^b   Tesfaye, Solomon ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Brain; Central nervous system; Diabetic peripheral neuropathy; Magnetic resonance imaging; Neuroimaging; Spine

Indexed keywords

ANALGESIC AGENT; GADOLINIUM CHELATE;

ARTICLE; BASEMENT MEMBRANE; BLOOD VOLUME; BOLD SIGNAL; BRAIN ATROPHY; BRAIN CORTEX; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBROVASCULAR ACCIDENT; CERVICAL SPINE; CLINICAL FEATURE; DIABETIC NEUROPATHY; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EVOKED SOMATOSENSORY RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; IN VIVO STUDY; INSULA; INSULIN DEPENDENT DIABETES MELLITUS; MICROANGIOPATHY; MILD COGNITIVE IMPAIRMENT; NERVE FUNCTION; NEUROIMAGING; NEUROMODULATION; NEUROTRANSMISSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERFUSION WEIGHTED IMAGING; PERIPHERAL NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIMARY SOMATOSENSORY CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SECONDARY SOMATOSENSORY CORTEX; SPINAL CORD; SYMPTOMATOLOGY; THALAMUS; THREE DIMENSIONAL IMAGING; TRACTOGRAPHY; VASCULARIZATION;

AXONS; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; DIABETIC NEUROPATHIES; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING;

EID: 84880137065     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-013-0394-8     Document Type: Article

References (54)

1. Tesfaye S. Advances in the management of painful diabetic neuropathy. Curr Opin Support Palliat Care. 2009;3:136-43.
2. Daousi C, MacFarlane IA, Woodward A, et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004;21:976-82.
3. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518-22.
4. Gore M, Brandenburg N, Dukes, et al. Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep. J Pain Symptoms Manage. 2005;30:374-85.
5. Zelman DC, Brandenburg NA, Gore M. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain. 2006;22:681-5.
6. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47(2):123-8.
7. Gore M, Brandenburg N, Hoffman DL, et al. Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives. J Pain. 2006;7(12):982-900.
8. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev. 2003;19:S2-8.
9. Jensen T, Baconja MM, Jimenez H, Tesfaye S, Valensi P, Ziegler. Management of diabetic neuropathic pain. Diab Vas Dis Res. 2006;3:108-19.
10. Tesfaye S, Vileikyte L, Rayman G, et al on behalf of the Toronto Expert Panel on diabetic neuropathy painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011. [Epub ahead of print].
11. Lukic IK, Humpert PM, Nawroth PP, Bierhaus A. The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy. Ann N Y Acad Sci. 2008;1126:76-80.
12. Obrosova IG. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics. 2009;6:638-47.
13. Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol. 2011;7:573-83.
14. Said G, Slama G, Selva J. Progressive centripital degeneration of axons in small-fiber type diabetic polyneuropathy. A clinical and pathological study. Brain. 1983;106:791.
15. Malik RA, Newrick PG, Sharma AK, et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia. 1989;32:92-102.
16. Tesfaye S, Malik R, Ward JD. Vascular factors in diabetic neuropathy. Diabetologia. 1994;37:847-54.
17. Malik RA, Tesfaye S, Thompson SD, et al. Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia. 1993;36:454-9.
18. Malik RA, Tesfaye S, Thompson SD, et al. Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvasc Res. 1994;48:236-45.
19. Giannini C, Dyck PJ. Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol. 1994;36:408-15.
20. Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJ, Wardlaw J, et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes. 2003;52:149-56.
21. Manschot SM, Brands AM, van der Grond J, et al. Utrecht Diabetic Encephalopathy Study Group. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006;55:1106-13.
22. Reske-Neilsen E, Lundbaek K, Rafaelsen OJ. Pathological changes in the central and peripheral nervous system of young long-term diabetics: II. Spinal cord and peripheral nerve. Diabetologia. 1968;4:34-43.
23. Slager UT. Diabetic myelopathy. Arch Pathol Lab Med. 1978;102:467-9.
24. Lauterbur PC. Image formation by induced local interactions: examples employing NMR. Nature. 1973;242:190-1.
25. Wilkinson ID, Paley MNJ. Magnetic resonance imaging: basic principles, Chapter 4. In: Grainger A, Adam D, editors. Diagnostic radiology: a textbook of medical imaging. 5th ed. Churchill Livingstone; 2007. Philadelphia, USA.
26. Ogawa S, Tank DW, Menon R, et al. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A. 1992;89:5951-5.
27. Boguslawska R, Romanowski CAJ, Wilkinson ID, et al. Introduction to functional magnetic resonance imaging. Med Sci Monit. 1999;5:1179-86.
28. Wilkinson ID. Perfusion and diffusion imaging in chronic carotid disease, Chapter 19. In: Gillard, Waldman, Barker, editors. Clinical MR neuroimaging: physiological and functional techniques. Cambridge University Press; Cambridge, UK, 2010.
29. Wilkinson ID, Paley M, Chong WK, et al. Proton spectroscopy in HIV infection: relaxation times of cerebral metabolites. Magn Reson Imaging. 1994;12:951-7.
30. Wilkinson ID, Lunn S, Miszkiel KA, et al. Proton MRS and quantitative MRI assessment of the short-term neurological response to anti-retroviral therapy in AIDS. J Neurol Neurosurg Psychiatry. 1997;63:477-82.
31. Puts NA, Edden RA. In vivo magnetic resonance spectroscopy of GABA: a methodological review. Prog Nucl Magn Reson Spectrosc. 2012;60:29-41.
32. Jones DK, editor. Diffusion MRI: theory, methods, and applications. Oxford University Press; Oxford, UK, 2010.
33. Eaton S, Harris ND, Rajbhandari SM, et al. Spinal cord involvement in diabetic peripheral neuropathy. Lancet. 2001;358:35-6.
34. Selvarajah D, Wilkinson ID, Emery CJ, et al. Early involvement of the spinal cord in diabetic peripheral neuropathy. Diabetes Care. 2006;29:2664-9.
35. Suzuki C, Ozaki I, Taosaki M, et al. Peripheral and central conduction abnormalities in diabetes mellitus. Neurology. 2000;54:1932-7.
36. Wilkinson ID, Selvarajah D, Hutton M, Griffiths PD, Gandhi R, Tesfaye S. Imaging of the cortico-spinal tracts in diabetic neuropathy using diffusion tensor magnetic resonance. Diabetes. 2009;58 (Supp 1): A214.
37. McCormick DA, Bal T. Sensory gating mechanisms of the thalamus. Curr Opin Neurobiol. 1994;4:550-6.
38. Selvarajah D, Wilkinson ID, Emery CJ, Shaw PJ, Griffiths PD, Gandhi R, et al. Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus. Diabetologia. 2008;51:2088-92.
39. Gandhi R, Selvarajah D, Emery CJ, Wilkinson ID, Tesfaye S. Neurochemical abnormalities within sensory pathways in the brain in diabetic neuropathy. Diabetologia. 2008;51(Supp 1):1-588.
40. Sorensen L, Siddall PJ, Trenell MI, Yue DK. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care. 2008;31:980-1.
41. Petrou M, Pop-Busui R, Foerster BR, Edden RA, et al. Altered excitation-inhibition balance in the brain of patients with diabetic neuropathy. Acad Radiol. 2012;19:607-12.
42. •• Selvarajah D, Wilkinson ID, Gandhi R, Griffiths PD, Tesfaye S. Microvascular perfusion abnormalities of the thalamus in painful but not painless diabetic polyneuropathy: a clue to the pathogenesis of pain in type 1 diabetes. Diabetes Care. 2011;34:718-20. Data from this preliminary study implies increased blood supply to the thalamus in patients with painful diabetic neuropathy.
43. Paulson PE, Wiley JW, Morrow TJ. Concurrent activation of the somatosensory forebrain and deactivation of periacqueductal gray associated with diabetes-induced neuropathic pain. Exp Neurol. 2007;208:305-13.
44. Fischer TZ, Tan AM, Waxman SG. Thalamic neuron hyperexcitability and enlarged receptive fields in the STZ model of diabetic pain. Brain Res. 2009;1268:154-61.
45. Melzack R. From the gate to the neuromatrix. Pain. 1999;(Suppl 6):S121-6.
46. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain. 2005;9:463-8.
47. Bushnell MC, Duncan GH, Hofbauer RK, et al. Pain perception: is there a role for primary somatosensory cortex? Proc Natl Acad Sci U S A. 1999;96:7705-9.
48. Kanda M, Nagamine T, Ikeda A, et al. Primary somatosensory cortex is actively involved in pain processing in human. Brain Res. 2000;853:282-9.
49. Peyron R, García-Larrea L, Grégoire MC, et al. Parietal and cingulate processes in central pain. A combined positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) study of an unusual case. Pain. 2000;84:77-87.
50. Wilkinson ID, Gandhi RA, Hunter MD, et al. Functional MRI and response to pain in diabetic neuropathy. Diabet Med. 2007;24 Suppl 1:187.
51. Wilkinson ID, Gandhi R, Hunter MD, et al. A functional magnetic resonance imaging study demonstrating alterations in brain responses to acute pain stimulation in diabetic neuropathy. Diabetologia. 2007;50(Supp 1):1-538.
52. Tseng MT, Chiang MC, Chao CC, Tseng WY, Hsieh, ST. fMRI evidence of degeneration-induced neuropathic pain in diabetes: enhanced limbic and striatal activations. Hum Brain Mapp. 2012. [Epub ahead of print].
53. • Manor B, Newton E, Abduljalil A, Novak V. The relationship between brain volume and walking outcomes in older adults with and without diabetic peripheral neuropathy. Diabetes Care. 2012;35:1907-12. In this study, patients' walking disability is linked with the presence of intracranial brain atrophy.
54. •• Selvarajah D, Maxwell M, Davies J, et al. Diabetic neuropathy associated with increased cortical atrophy on brain MRI in patients with Type-1 Diabetes. Diabetic Med. 2013;30 Suppl 1:14. This work identifies atrophy of the somatosensory cortex in people with diabetic neuropathy.